Product NDC: | 60505-2519 |
Proprietary Name: | Citalopram |
Non Proprietary Name: | citalopram hydrobromide |
Active Ingredient(s): | 20 mg/1 & nbsp; citalopram hydrobromide |
Administration Route(s): | ORAL |
Dosage Form(s): | TABLET, FILM COATED |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 60505-2519 |
Labeler Name: | Apotex Corp. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA077046 |
Marketing Category: | ANDA |
Start Marketing Date: | 20110801 |
Package NDC: | 60505-2519-1 |
Package Description: | 100 TABLET, FILM COATED in 1 BOTTLE (60505-2519-1) |
NDC Code | 60505-2519-1 |
Proprietary Name | Citalopram |
Package Description | 100 TABLET, FILM COATED in 1 BOTTLE (60505-2519-1) |
Product NDC | 60505-2519 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | citalopram hydrobromide |
Dosage Form Name | TABLET, FILM COATED |
Route Name | ORAL |
Start Marketing Date | 20110801 |
Marketing Category Name | ANDA |
Labeler Name | Apotex Corp. |
Substance Name | CITALOPRAM HYDROBROMIDE |
Strength Number | 20 |
Strength Unit | mg/1 |
Pharmaceutical Classes | Serotonin Reuptake Inhibitor [EPC],Serotonin Uptake Inhibitors [MoA] |